US Stock MarketDetailed Quotes

BCRX BioCryst Pharmaceuticals

Watchlist
  • 10.080
  • -0.190-1.85%
Close May 7 16:00 ET
  • 10.080
  • 0.0000.00%
Pre 05:11 ET
2.11BMarket Cap-38.77P/E (TTM)

BioCryst Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
-12.32%295.09M
-17.52%320.85M
-17.52%320.85M
-17.00%330.01M
-33.76%272.03M
-15.47%336.55M
-8.32%388.99M
-8.32%388.99M
-6.86%397.59M
-1.63%410.67M
-Cash and cash equivalents
24.73%105.19M
-5.36%104.71M
-5.36%104.71M
-35.83%96.84M
-46.37%78.41M
-45.64%84.33M
-63.70%110.64M
-63.70%110.64M
-38.88%150.91M
-46.36%146.22M
-Short-term investments
-24.71%189.9M
-22.35%216.14M
-22.35%216.14M
-5.48%233.17M
-26.79%193.62M
3.79%252.22M
132.84%278.34M
132.84%278.34M
37.08%246.69M
82.49%264.46M
Receivables
54.15%93.39M
38.84%79.07M
38.84%79.07M
35.06%72.46M
19.23%68.76M
24.56%60.59M
12.55%56.95M
12.55%56.95M
25.90%53.65M
38.99%57.67M
-Accounts receivable
54.15%93.39M
38.84%79.07M
38.84%79.07M
35.06%72.46M
19.23%68.76M
24.56%60.59M
12.55%56.95M
12.55%56.95M
25.90%53.65M
38.99%57.67M
Inventory
-76.92%6.87M
-71.81%8.09M
-71.81%8.09M
-74.48%7.56M
-83.54%4.45M
8.43%29.78M
4.18%28.68M
4.18%28.68M
9.66%29.63M
15.63%27.03M
Restricted cash
-83.82%291K
-88.36%210K
-88.36%210K
-48.67%813K
14.04%1.8M
22.90%1.8M
22.55%1.8M
22.55%1.8M
9.70%1.58M
8.70%1.57M
Other current assets
-22.06%14.33M
-29.63%13.75M
-29.63%13.75M
-18.66%16.28M
16.40%16.43M
21.27%18.38M
55.27%19.54M
55.27%19.54M
80.81%20.02M
27.68%14.11M
Total current assets
-8.30%409.98M
-14.92%421.97M
-14.92%421.97M
-14.99%427.13M
-28.88%363.46M
-8.92%447.1M
-3.98%495.97M
-3.98%495.97M
-1.28%502.47M
3.27%511.06M
Non current assets
Net PPE
149.97%19.58M
-5.40%19.79M
-5.40%19.79M
-63.73%7.42M
-50.19%7.66M
-49.22%7.83M
142.71%20.91M
142.71%20.91M
34.05%20.46M
-1.92%15.38M
-Gross PPE
--19.58M
0.03%32.13M
0.03%32.13M
----
----
----
76.83%32.12M
76.83%32.12M
40.10%26.81M
8.94%20.84M
-Accumulated depreciation
----
-10.16%-12.35M
-10.16%-12.35M
----
----
----
-17.38%-11.21M
-17.38%-11.21M
-63.91%-6.35M
-58.46%-5.45M
Investments and advances
--20.55M
--20.32M
--20.32M
--19.43M
1,766.97%64.32M
----
--0
--0
--0
--3.45M
Other non current assets
131.05%29.95M
35,330.00%28.34M
35,330.00%28.34M
--37.28M
--36.98M
--12.96M
-98.82%80K
-98.82%80K
----
----
Total non current assets
237.00%70.07M
226.06%68.45M
226.06%68.45M
213.47%64.13M
478.69%108.96M
10.28%20.79M
-37.33%20.99M
-37.33%20.99M
-58.75%20.46M
20.04%18.83M
Total assets
2.60%480.05M
-5.13%490.42M
-5.13%490.42M
-6.06%491.25M
-10.84%472.42M
-8.21%467.89M
-6.01%516.96M
-6.01%516.96M
-6.39%522.92M
3.79%529.89M
Liabilities
Current liabilities
Payables
-15.63%10.05M
-33.44%26.23M
-33.44%26.23M
27.59%13.48M
-43.94%7.79M
90.44%11.91M
78.71%39.42M
78.71%39.42M
22.56%10.57M
15.51%13.89M
-accounts payable
-15.63%10.05M
-44.27%11.64M
-44.27%11.64M
27.59%13.48M
-43.94%7.79M
90.44%11.91M
45.53%20.89M
45.53%20.89M
22.56%10.57M
15.51%13.89M
-Other payable
----
-21.24%14.59M
-21.24%14.59M
----
----
----
140.57%18.52M
140.57%18.52M
----
----
Current accrued expenses
16.89%92.64M
-15.83%17.96M
-15.83%17.96M
34.64%104.2M
18.99%89.6M
5.37%79.25M
-50.86%21.33M
-50.86%21.33M
11.73%77.39M
-5.53%75.3M
Current provisions
----
21.15%32.12M
21.15%32.12M
----
----
----
84.96%26.51M
84.96%26.51M
----
----
Current debt and capital lease obligation
4.60%2.87M
4.68%2.77M
4.68%2.77M
26.56%2.89M
7.00%2.71M
10.00%2.74M
11.78%2.65M
11.78%2.65M
3.92%2.28M
18.56%2.53M
-Current capital lease obligation
4.60%2.87M
4.68%2.77M
4.68%2.77M
26.56%2.89M
7.00%2.71M
10.00%2.74M
11.78%2.65M
11.78%2.65M
3.92%2.28M
18.56%2.53M
Current deferred liabilities
----
----
----
----
----
----
----
----
-66.41%522K
16.96%1.78M
Other current liabilities
31.83%34.31M
38.66%32.68M
38.66%32.68M
--33M
--28.97M
--26.02M
--23.57M
--23.57M
----
----
Current liabilities
16.62%139.86M
6.93%160.38M
6.93%160.38M
69.20%153.57M
38.04%129.07M
40.82%119.92M
42.15%149.99M
42.15%149.99M
11.18%90.76M
-1.98%93.5M
Non current liabilities
Long term debt and capital lease obligation
-3.89%792.12M
-2.01%805.97M
-2.01%805.97M
-4.38%806.25M
-0.74%818.96M
9.47%824.14M
11.29%822.5M
11.29%822.5M
17.17%843.15M
447.46%825.1M
-Long term debt
-3.81%782.03M
-1.89%795.92M
-1.89%795.92M
-4.45%796.11M
-1.32%808.48M
8.85%813.04M
10.64%811.27M
10.64%811.27M
16.75%833.18M
466.92%819.3M
-Long term capital lease obligation
-9.09%10.09M
-10.57%10.05M
-10.57%10.05M
1.77%10.14M
80.58%10.48M
87.09%11.1M
93.57%11.24M
93.57%11.24M
66.99%9.97M
-6.37%5.8M
Total non current liabilities
-3.89%792.12M
-2.01%805.97M
-2.01%805.97M
-4.38%806.25M
-0.74%818.96M
9.47%824.14M
11.29%822.5M
11.29%822.5M
17.17%843.15M
31.31%825.1M
Total liabilities
-1.28%931.97M
-0.63%966.35M
-0.63%966.35M
2.77%959.82M
3.20%948.03M
12.65%944.06M
15.14%972.49M
15.14%972.49M
16.56%933.91M
26.92%918.6M
Shareholders'equity
Share capital
1.41%2.09M
1.31%2.09M
1.31%2.09M
9.11%2.07M
9.02%2.07M
9.21%2.06M
9.53%2.06M
9.53%2.06M
1.82%1.9M
1.94%1.9M
-common stock
1.41%2.09M
1.31%2.09M
1.31%2.09M
9.11%2.07M
9.02%2.07M
9.21%2.06M
9.53%2.06M
9.53%2.06M
1.82%1.9M
1.94%1.9M
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-3.11%-1.77B
-5.29%-1.77B
-5.29%-1.77B
-7.65%-1.74B
-9.22%-1.73B
-13.83%-1.72B
-15.57%-1.68B
-15.57%-1.68B
-17.09%-1.62B
-18.11%-1.58B
Paid-in capital
6.25%1.31B
5.63%1.29B
5.63%1.29B
5.36%1.27B
4.95%1.25B
5.13%1.24B
5.54%1.22B
5.54%1.22B
5.89%1.21B
5.91%1.19B
Gains losses not affecting retained earnings
46.82%1.13M
-31.11%921K
-31.11%921K
186.63%2.29M
-19.28%557K
31.79%771K
5,042.31%1.34M
5,042.31%1.34M
916.33%800K
4,500.00%690K
Total stockholders'equity
5.09%-451.93M
-4.48%-475.93M
-4.48%-475.93M
-14.01%-468.56M
-22.35%-475.61M
-45.05%-476.17M
-54.63%-455.53M
-54.63%-455.53M
-69.37%-410.99M
-82.30%-388.71M
Total equity
5.09%-451.93M
-4.48%-475.93M
-4.48%-475.93M
-14.01%-468.56M
-22.35%-475.61M
-45.05%-476.17M
-54.63%-455.53M
-54.63%-455.53M
-69.37%-410.99M
-82.30%-388.71M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Assets
Current assets
Cash, cash equivalents and short term investments -12.32%295.09M-17.52%320.85M-17.52%320.85M-17.00%330.01M-33.76%272.03M-15.47%336.55M-8.32%388.99M-8.32%388.99M-6.86%397.59M-1.63%410.67M
-Cash and cash equivalents 24.73%105.19M-5.36%104.71M-5.36%104.71M-35.83%96.84M-46.37%78.41M-45.64%84.33M-63.70%110.64M-63.70%110.64M-38.88%150.91M-46.36%146.22M
-Short-term investments -24.71%189.9M-22.35%216.14M-22.35%216.14M-5.48%233.17M-26.79%193.62M3.79%252.22M132.84%278.34M132.84%278.34M37.08%246.69M82.49%264.46M
Receivables 54.15%93.39M38.84%79.07M38.84%79.07M35.06%72.46M19.23%68.76M24.56%60.59M12.55%56.95M12.55%56.95M25.90%53.65M38.99%57.67M
-Accounts receivable 54.15%93.39M38.84%79.07M38.84%79.07M35.06%72.46M19.23%68.76M24.56%60.59M12.55%56.95M12.55%56.95M25.90%53.65M38.99%57.67M
Inventory -76.92%6.87M-71.81%8.09M-71.81%8.09M-74.48%7.56M-83.54%4.45M8.43%29.78M4.18%28.68M4.18%28.68M9.66%29.63M15.63%27.03M
Restricted cash -83.82%291K-88.36%210K-88.36%210K-48.67%813K14.04%1.8M22.90%1.8M22.55%1.8M22.55%1.8M9.70%1.58M8.70%1.57M
Other current assets -22.06%14.33M-29.63%13.75M-29.63%13.75M-18.66%16.28M16.40%16.43M21.27%18.38M55.27%19.54M55.27%19.54M80.81%20.02M27.68%14.11M
Total current assets -8.30%409.98M-14.92%421.97M-14.92%421.97M-14.99%427.13M-28.88%363.46M-8.92%447.1M-3.98%495.97M-3.98%495.97M-1.28%502.47M3.27%511.06M
Non current assets
Net PPE 149.97%19.58M-5.40%19.79M-5.40%19.79M-63.73%7.42M-50.19%7.66M-49.22%7.83M142.71%20.91M142.71%20.91M34.05%20.46M-1.92%15.38M
-Gross PPE --19.58M0.03%32.13M0.03%32.13M------------76.83%32.12M76.83%32.12M40.10%26.81M8.94%20.84M
-Accumulated depreciation -----10.16%-12.35M-10.16%-12.35M-------------17.38%-11.21M-17.38%-11.21M-63.91%-6.35M-58.46%-5.45M
Investments and advances --20.55M--20.32M--20.32M--19.43M1,766.97%64.32M------0--0--0--3.45M
Other non current assets 131.05%29.95M35,330.00%28.34M35,330.00%28.34M--37.28M--36.98M--12.96M-98.82%80K-98.82%80K--------
Total non current assets 237.00%70.07M226.06%68.45M226.06%68.45M213.47%64.13M478.69%108.96M10.28%20.79M-37.33%20.99M-37.33%20.99M-58.75%20.46M20.04%18.83M
Total assets 2.60%480.05M-5.13%490.42M-5.13%490.42M-6.06%491.25M-10.84%472.42M-8.21%467.89M-6.01%516.96M-6.01%516.96M-6.39%522.92M3.79%529.89M
Liabilities
Current liabilities
Payables -15.63%10.05M-33.44%26.23M-33.44%26.23M27.59%13.48M-43.94%7.79M90.44%11.91M78.71%39.42M78.71%39.42M22.56%10.57M15.51%13.89M
-accounts payable -15.63%10.05M-44.27%11.64M-44.27%11.64M27.59%13.48M-43.94%7.79M90.44%11.91M45.53%20.89M45.53%20.89M22.56%10.57M15.51%13.89M
-Other payable -----21.24%14.59M-21.24%14.59M------------140.57%18.52M140.57%18.52M--------
Current accrued expenses 16.89%92.64M-15.83%17.96M-15.83%17.96M34.64%104.2M18.99%89.6M5.37%79.25M-50.86%21.33M-50.86%21.33M11.73%77.39M-5.53%75.3M
Current provisions ----21.15%32.12M21.15%32.12M------------84.96%26.51M84.96%26.51M--------
Current debt and capital lease obligation 4.60%2.87M4.68%2.77M4.68%2.77M26.56%2.89M7.00%2.71M10.00%2.74M11.78%2.65M11.78%2.65M3.92%2.28M18.56%2.53M
-Current capital lease obligation 4.60%2.87M4.68%2.77M4.68%2.77M26.56%2.89M7.00%2.71M10.00%2.74M11.78%2.65M11.78%2.65M3.92%2.28M18.56%2.53M
Current deferred liabilities ---------------------------------66.41%522K16.96%1.78M
Other current liabilities 31.83%34.31M38.66%32.68M38.66%32.68M--33M--28.97M--26.02M--23.57M--23.57M--------
Current liabilities 16.62%139.86M6.93%160.38M6.93%160.38M69.20%153.57M38.04%129.07M40.82%119.92M42.15%149.99M42.15%149.99M11.18%90.76M-1.98%93.5M
Non current liabilities
Long term debt and capital lease obligation -3.89%792.12M-2.01%805.97M-2.01%805.97M-4.38%806.25M-0.74%818.96M9.47%824.14M11.29%822.5M11.29%822.5M17.17%843.15M447.46%825.1M
-Long term debt -3.81%782.03M-1.89%795.92M-1.89%795.92M-4.45%796.11M-1.32%808.48M8.85%813.04M10.64%811.27M10.64%811.27M16.75%833.18M466.92%819.3M
-Long term capital lease obligation -9.09%10.09M-10.57%10.05M-10.57%10.05M1.77%10.14M80.58%10.48M87.09%11.1M93.57%11.24M93.57%11.24M66.99%9.97M-6.37%5.8M
Total non current liabilities -3.89%792.12M-2.01%805.97M-2.01%805.97M-4.38%806.25M-0.74%818.96M9.47%824.14M11.29%822.5M11.29%822.5M17.17%843.15M31.31%825.1M
Total liabilities -1.28%931.97M-0.63%966.35M-0.63%966.35M2.77%959.82M3.20%948.03M12.65%944.06M15.14%972.49M15.14%972.49M16.56%933.91M26.92%918.6M
Shareholders'equity
Share capital 1.41%2.09M1.31%2.09M1.31%2.09M9.11%2.07M9.02%2.07M9.21%2.06M9.53%2.06M9.53%2.06M1.82%1.9M1.94%1.9M
-common stock 1.41%2.09M1.31%2.09M1.31%2.09M9.11%2.07M9.02%2.07M9.21%2.06M9.53%2.06M9.53%2.06M1.82%1.9M1.94%1.9M
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -3.11%-1.77B-5.29%-1.77B-5.29%-1.77B-7.65%-1.74B-9.22%-1.73B-13.83%-1.72B-15.57%-1.68B-15.57%-1.68B-17.09%-1.62B-18.11%-1.58B
Paid-in capital 6.25%1.31B5.63%1.29B5.63%1.29B5.36%1.27B4.95%1.25B5.13%1.24B5.54%1.22B5.54%1.22B5.89%1.21B5.91%1.19B
Gains losses not affecting retained earnings 46.82%1.13M-31.11%921K-31.11%921K186.63%2.29M-19.28%557K31.79%771K5,042.31%1.34M5,042.31%1.34M916.33%800K4,500.00%690K
Total stockholders'equity 5.09%-451.93M-4.48%-475.93M-4.48%-475.93M-14.01%-468.56M-22.35%-475.61M-45.05%-476.17M-54.63%-455.53M-54.63%-455.53M-69.37%-410.99M-82.30%-388.71M
Total equity 5.09%-451.93M-4.48%-475.93M-4.48%-475.93M-14.01%-468.56M-22.35%-475.61M-45.05%-476.17M-54.63%-455.53M-54.63%-455.53M-69.37%-410.99M-82.30%-388.71M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
QIFENG
873169
+29.99%
Jin Tong Ling Technology Group
300091
+20.16%
Jinlong Machinery & Electronic
300032
+20.08%
4
Qingdao Gaoce Technology
688556
+20.02%
5
Aerospace Nanhu Electronic Information Technology
688552
+20.02%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025